References
- Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011; 11(12): 886–895. doi: 10.1038/nrc3174.
- Owiecki M. Otyłość epidemią XXI wieku. Przegląd Kardiodiabetologiczny. 2009; 36–41.
- Ahima RS, Flier JS. Leptin and the regulation of body weight in mammals. N Engl J Med. 2000; 341(13): 909-915.
- Goday A, Barneto I, García-Almeida JM, et al. Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology. Clin Transl Oncol. 2015; 17(10): 763–771. doi: 10.1007/s12094-015-1306-y.
- Siemińska L. Tkanka tłuszczowa. Patofizjologia, rozmieszczenie, różnice płciowe oraz znaczenie w procesach zapalnych i nowotworowych. Endokrynol Pol. 2007; 58(4): 330–343.
- Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1): 79–83.
- Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008; 8(12): 915-928. doi: 10.1038/nrc2536.
- Gallagher EJ, LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab. 2010; 21(10): 610-618. doi: 10.1016/j.tem.2010.06.007.
- Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/ insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 2009; 30(6): 586-623. doi: 10.1210/er.2008-0047.
- Subbaramaiah K, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res. 2011; 4(3): 329–346.
- Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4(8): 579–591.
- Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: The estrogen connection. Endocrinology. 2009; 150(6): 2537–2542.
- Pasquali R, et al. Pathophysiology of obesity in polycystic ovary syndrome: Role of adiposity and insulin resistance. J Endocrinol Invest. 2006; 29(3): 54–62.
- Schindler AE. Progestogen deficiency and endometrial cancer risk. Maturitas. 2009; 4: 334-337.
- Emons G, Fleckenstein G, Hinney B, et al. Hormonal interactions in endometrial cancer. Endocr Relat Cancer. 2000; 4: 227-242.
- Duleba AJ, Dokras A. Is PCOS an inflammatory process? Fertil Steril. 2012; 97: 7–12.
- Dumesic DA, Lobo RA. Cancer risk and PCOS. Steroids. 2013; 78: 782–785.
- Bryant W, Snowhite AE, Rice LW, Shupnik MA. The estrogen receptor (ER)α variant Δ5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells. Endocrinology. 2005; 2: 751-759.
- Foksiński M, Piekutowski M, Roszkowski K, Oliński R. Rola estrogenów w procesie karcinogenezy. Współcz Onkol. 2002; 3: 137-140.
- Bardia A, Vachon CM, Olson JE, et al. Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2008; 17: 374-8.
- Micozzi MS. Cross-cultural correlations of childhood growth and adult breast cancer. Am J Phys Anthropol. 1987; 73: 525-37.
- Brinton LA, Schairer C, Hoover RN. Menstrual factors and risk of breast cancer. Cancer Invest. 2001; 6: 245-54.
- Willis D. Does estrogen replacement therapy reduce the risk of fatal breast cancer in postmenopausal women? Maturitas. 1997; 37: 105-108.
- Makowski M, Połać I, Pertyński T. Estrogeny a rak sutka. Prz Menopauz. 2007; 3: 150–154.
- Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003; 22: 5108-21.
- Grodecka-Gazdecka S. Association between obesity and breast cancer. Forum Zaburzeń Metabolicznych. 2011; 4(2): 231-238.
- Jarde T, Perrier S, Vasson MP, et al. Molecular mechanism of leptin and adiponectin. Eur J Cancer. 2011; 47: 33-34.
- Consedine NS, Magai C, Conway F, et al. Obesity and awareness of obesity as risk factors for breast cancer in six ethnic groups. Obes Res. 2004; 12: 1680–9.
- Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med. 1997; 216: 28–43.
- Roszak M, Litwiniuk M, Gazdecka S. Otyłość a rak piersi. Współcz Onkol. 2010; 14(4): 270-275.
- Rosato V, Bosetti C, Talamini R, et al. Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol. 2011; 22(12): 2687-2692.
- Purdie D, Green A. Epidemiology of ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2001; 15(3): 355-370.
- Au CC, et al. The role of adipokines in ovarian cancer cell proliferation and migration. Int J Oncol. 2009; 35(5): 1151-1159.
- Kyrgiou M, et al. Adiposity and cancer at major anatomical sites: Umbrella review of the literature. BMJ. 2015; 350: g7647.
- Schouten LJ, Rivera C, Hunter DJ, et al. Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev. 2008; 17: 902-912.
- Marchesi JR, Dutilh BE, Hall N, et al. Towards the Human Colorectal Cancer Microbiome. PLoS ONE. 2011; 6: e204–247.
- Nowak A, Libudzisz Z. Karcynogenna aktywność mikroorganizmów jelitowych. Żywność. Nauka. Technologia. Jakość. 2008; 6: 25–39.
- Tilg H, Kaser A. Gut microbiome, obesity and metabolic syndrome. J Clin Invest. 2011; 121: 2126–2132.
- Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight R. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 2005; 102: 11070–11075.